FDA official logo
GSRS logo
PFDA official logo

NALTREXONE HYDROCHLORIDE

  • UNII: Z6375YW9SF
  • Formula: C20H23NO4.ClH
  • Preferred Substance Name: NALTREXONE HYDROCHLORIDE
  • InChIKey: RHBRMCOKKKZVRY-ITLPAZOVSA-N

  • 16676-29-2
  • 240-723-0
  • 17-CYCLOPROPYLMETHYL)-4,5.ALPHA.-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE HYDROCHLORIDE
  • CONTRAVE COMPONENT NALTREXONE HYDROCHLORIDE
  • EMBEDA COMPONENT NALTREXONE HYDROCHLORIDE
  • EN-1639A
  • EN-1639A (AS HYDROCHLORIDE)
  • MORPHINAN-6-ONE, 17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-3,14-DIHYDROXY-, HYDROCHLORIDE, (5.ALPHA.)-
  • NALTREXONE HCL
  • NALTREXONE HYDROCHLORIDE [EP MONOGRAPH]
  • NALTREXONE HYDROCHLORIDE [GREEN BOOK]
  • NALTREXONE HYDROCHLORIDE [MART.]
  • NALTREXONE HYDROCHLORIDE [MI]
  • NALTREXONE HYDROCHLORIDE [ORANGE BOOK]
  • NALTREXONE HYDROCHLORIDE [USP MONOGRAPH]
  • NALTREXONE HYDROCHLORIDE [VANDF]
  • NALTREXONE HYDROCHLORIDE [WHO-DD]
  • NALTREXONE HYDROCHLORIDE COMPONENT OF CONTRAVE
  • NALTREXONE HYDROCHLORIDE COMPONENT OF EMBEDA
  • NALTREXONE HYDROCHLORIDE COMPONENT OF TROXYCA
  • REVIA
  • TREXAN
  • TROXYCA COMPONENT NALTREXONE HYDROCHLORIDE

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.




About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

Powered by

DNAnexus official logo